Valion Bio (VBIO) Other Working Capital Changes (2021 - 2025)
Valion Bio (VBIO) posted quarterly Other Working Capital Changes of -$273000.0 for Q4 2024, down 493.48% year-over-year from $69381.2 in Q1 2024, and down 1505.88% quarter-over-quarter from -$17000.0 in Q3 2024.
Valion Bio (VBIO) Other Working Capital Changes (2021 - 2025) Analysis & Trends
Valion Bio's Other Working Capital Changes history runs 3 years deep, the most recent figure standing at -$273000.0 for Q4 2024.
- In Q4 2024, Other Working Capital Changes fell 493.48% year-over-year to -$273000.0; the TTM figure through Dec 2025 stood at -$321000.0 (up 13.01% YoY), while the FY2024 annual figure was -$369000.0, down 129.19% from the prior year.
- Other Working Capital Changes for Q4 2024 stood at -$273000.0, down from -$17000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $737000.0 in Q4 2021, with the low at -$220000.0 in Q2 2022.
- The 5-year median for Other Working Capital Changes is -$19000.0 (2023), against an average of $39473.7.
- Peak annual rise in Other Working Capital Changes reached 62.22% in 2024, while the deepest fall reached 493.48% in 2024.
- Valion Bio's Other Working Capital Changes stood at -$43000.0 in 2022, then dropped by 6.98% to -$46000.0 in 2023, then slumped by 493.48% to -$273000.0 in 2024.
- Business Quant data shows VBIO's Other Working Capital Changes at -$273000.0 in Q4 2024, -$17000.0 in Q3 2024, and -$31000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Valion Bio | 405,599.63 | -1.79 Mn | -45,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -23,000.00 |
| Dec 31, 2025 | -23,000.00 |
| Dec 31, 2025 | -23,000.00 |
| Sep 30, 2025 | -90,000.00 |
| Sep 30, 2025 | -90,000.00 |
| Sep 30, 2025 | -90,000.00 |
| Jun 30, 2025 | 89,000.00 |
| Jun 30, 2025 | 89,000.00 |
| Jun 30, 2025 | 89,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Mar 31, 2025 | 24,000.00 |
| Sep 30, 2024 | 105,000.00 |
| Sep 30, 2024 | 105,000.00 |
| Sep 30, 2024 | 105,000.00 |
| Jun 30, 2024 | -62,000.00 |
| Jun 30, 2024 | -62,000.00 |
| Jun 30, 2024 | -62,000.00 |
| Mar 31, 2024 | -77,000.00 |
| Mar 31, 2024 | -77,000.00 |